Disposable Hemoperfusion Market Size, Share, Growth, and Industry Analysis, By Type (Charcoal Hemoperfusion & Certain Resins Hemoperfusion), By Application (Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, & Others) and Regional Forecast to 2033

DISPOSABLE HEMOPERFUSION MARKET REPORT OVERVIEW

The global Disposable Hemoperfusion Market size was valued at USD 1198.07 million in 2024 and is projected to reach USD 1346.63 Million in 2025, growing to USD 3430.67 Million by 2033, with exhibiting CAGR of 12.4% during the forecast period.

The global Disposable Hemoperfusion Market has experienced tremendous growth in recent years, fueled by technological innovation and growing demand from different industries. The market has grown consistently over the historical period 2020-2023, with high investments driving innovation. In the future, the forecasted period of 2025-2033 is anticipated to experience rapid growth, fueled by growing adoption and new market trends. The industry is led by the top three major players - Kaneka Pharma, Aier, Baxter International , who are still leading through strategic growth and product development. Top Growing Region Asia-Pacific is expected to grow at the fastest rate, driven by rising industrialization, digitalization, and supportive government policies.

Hemoperfusion is a medical treatment for removal of toxic substances from blood. In this treatment large volumes of blood of patients are moved through an adsorbent substance. The adsorption is a procedure that can hold a particle or molecule on the surface of solid material and retain them there. The solid market is known as sorbent. A disposable type of hemoperfusion is an extracorporeal form of treatment. It pumps blood through a device outside of the body of a patient.

Increasing use of adsorbent substances in therapy of toxic substances and poisons is pushing the market growth. Rising ventures in developing countries and industries are providing chances for market expansion.

COVID-19 Impact

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

COVID-19 pandemic has raised research activities. Rising investment in research works has increased businesses profits. In pandemic, vaccine requirement has increased acceptance of products. Rapid testing and research for antibodies are in high demand which developed market growth. The pandemic allows for doing research for short-term and long-term situations. This has increased market expansion in the pandemic period and created opportunities for expansion after-pandemic.

LATEST TRENDS

"Growing Demand for Biocompatible Materials Boost Market Growth"

Current trend in the market is the increasing demand for biocompatible material for hemoperfusion is boosting the market growth. High demand of sustainable materials by the end-users is pushing market players to integrated biocompatible markets. Another trend in the market is the adoption of nanotechnology for manufacturing disposable hemoperfusion devices that is enhancing market growth. This incorporation of nanotechnology will improve and enhance efficiency and precision.

DISPOSABLE HEMOPERFUSION MARKET SEGMENTATION

By Type

Based on type the market can be categorized into Charcoal Hemoperfusion & Certain Resins Hemoperfusion

• Charcoal Hemoperfusion: Charcoal hemoperfusion is a sorbent which can adsorbs a toxin after contact with the blood and is used for treatment of liver failure and acute poisoning.
• Certain Resins Hemoperfusion: Certain resins hemoperfusion is more effectively clean lipid-soluble drugs than charcoal type hemoperfusion.

By Application

Based on application the market can be categorized into Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, & Others

• Overdose, Specific Intoxications: Hemoperfusion is used for the treatment of specific intoxication and overdose such as valproic acid, theophylline, and meprobamate.
• Certain Autoimmune Diseases: Hemoperfusion is used as an admirable adjuvant treatment for certain autoimmune diseases and it effectively Hepatic Encephalopathy removes pathogenic factors from the blood of patients.
• Hepatic Encephalopathy: Hemoperfusion is used for treatment of hepatic encephalopathy which eliminates endotoxin and cytokine and it supports in treatment of liver failure.
• Others: Hemoperfusion is used for the treatment of many other diseases and disorders for removing toxic substances from blood of patients such as hepatic coma, metabolic disturbance.

DRIVING FACTORS

"Adoption of Personalized Medicine Propel Market Expansion"

One of the attributes for the Disposable Hemoperfusion Market Growth due to increasing adoption of personalized medicines and therapeutics procedures propelling market growth. Rising integration of personalization of medicine is increasing customization in hemoperfusion disposable treatments. Development of portable and wearable devices which are easy to use in home settings is propelling the demand as consequently enhancing market progress.

"Rising Number of Diabetes Cases Fuel Market Progress"

Another attribute for the market growth is the increasing cases of diabetes in population impelling market expansion. Growing number of disorders and viruses such as liver cirrhosis, renal failure, and others are increasing demand for the device and encouraging the market growth. The technical improvement in systems allows effective treatment and improves experience. Populations are gaining weight which leads to diabetes that increases organ failure and raises demand for hemoperfusion. These factors support improvement of products and increase market growth.

RESTRAINING FACTOR

"Limited Awareness about Hemoperfusion Hamper Market Progress"

Limiting factor for the market growth is the limited awareness about hemoperfusion treatment among the population is hampering expansion of the market. There is a requirement for stringent regulatory for hemoperfusion therapy in healthcare centers which is a constraint for the market growth. Additionally, risk of side effects associated with the therapy such as blood coagulation, organ failure, and others are hindering progress of this market. This treatment is expensive which deter people to avail the facility and decrease demand for the products. Hence, the high cost of the therapy is discouraging market expansion.

OPPORTUNITY

"Rising Incidence of Sepsis and Kidney Disorders "

Over 48 million sepsis cases occur globally each year, with hemoperfusion being a critical therapy for severe cases requiring toxin removal.

"Increased Government Healthcare Spending "

Public health expenditures have surpassed $9 trillion globally, leading to greater funding for advanced blood purification technologies like disposable hemoperfusion devices.

CHALLENGES

"Limited Adoption in Low-Income Regions "

Over 3 billion people lack access to advanced medical treatments, restricting the widespread use of disposable hemoperfusion systems.

"Stringent Regulatory Approvals "

More than 50 countries enforce strict medical device approval processes, delaying market entry and increasing compliance costs for manufacturers.

DISPOSABLE HEMOPERFUSION MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

• 

  To Know Key Insights of the Market

  Request Free Sample

"Asia Pacific Dominates the Market due to Rising Poisoning Incidents"

The Asia Pacific region is dominating the Disposable Hemoperfusion Market Share due to the increasing number of poisoning cases in this region. Increasing investment in healthcare sectors in developing countries is propelling the market growth. Providing hemoperfusion support to patients before and after transplantation of liver failure is increasing demand for products and therapy and increasing market share. Rapid expansion of urbanization and increasing incomes are enhancing demand for products and services of hemoperfusion. China, Japan, India, and South Korea are major contributors to the market growth in this region.

KEY INDUSTRY PLAYERS

"Key Players Transforming the Disposable Hemoperfusion Landscape through Partnership and Other Business Strategies"

Many prominent industry players are operating in this market focused on expanding market presence through partnership strategy. However, there are many companies in the market that use some techniques such as merger, acquisitions, and using new advanced technologies for producing and developing new products and stay ahead in the market.

List of Top Industry Players

• Baxter International (U.S.)
• Asahi Kasei Corporation (Japan)
• CytoSorbentsCompany 11 (U.S.)
• Kaneka Pharma (Japan)
• Toray Medical (Japan)
• Aier (China)
• Tianjin Zibo High Technology (China)
• Biosun Corporation (Iran)
• Kangbei Medical Device (China)
• Jafron Biomedical (China)

INDUSTRIAL DEVELOPMENT

June 2021: Jafron Biomedical is a leading blood-purifying giant, announced the foundation of a worldwide advisory board. This advisory board consists of six members which are non-commercials and industry experts. The aim for creating this team is to provide guidance about hemoadsorption therapy based on reliable data.

REPORT COVERAGE

This report is based on historical analysis and forecast calculation that aims to help readers get a comprehensive understanding of the global disposable hemoperfusion market size from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the growth of the market by discovering the dynamic categories and potential areas of innovation whose applications may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points into consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.